NSECopy of Newspaper Publication11 Aug 2026 · 11 Aug 2026, 06:24 pm
Copy of Newspaper Publication
Jubilant Pharmova Limited · JUBLPHARMA
✦ AI SummaryResults
Jubilant Pharmova Limited has submitted copies of published unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, to the NSE, as per Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication
Attachments (1)
📄pdf
Download →
JUBLPHARMA_11082026182427_Intimation_-_Financial_in_Newspaper_signed.pdf
View document text
August 11, 2026
BSE Limited National Stock Exchange of India Limited
Floor 25, P. J. Towers Exchange Plaza
Dalal Street, Fort Bandra Kurla Complex, Bandra (E)
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 530019 Symbol: JUBLPHARMA
Sub: Submission of copies of published Unaudited Standalone and Consolidated Financial
Results for the quarter ended June 30, 2026
Dear Sirs,
Pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, please find enclosed copies of Financial Express (English) and
Hindustan & Jansatta (Hindi) newspapers dated August 11, 2026, in which Quick Response Code
(QR Code) and the details of the webpage where complete Unaudited financial results of the
Company for the quarter ended June 30, 2026, accessible to the Investors, have been published.
The aforesaid results were approved by the Board of Directors in their meeting held on
August 10, 2026.
We request you to take the same on record.
Thanking you,
Yours faithfully,
For Jubilant Pharmova Limited
Naresh Kapoor
Company Secretary
Encl: As above